To individually validate TRA2A dependency, we selected a panel of TRA2A-dependent cell lines (NCI-H23, NCI-H2286, LN319, PANC0504) and tumor type-matched TRA2A-independent cell lines (A549, LN229, AsPC-1). The gene discussed is TRA2A; the disease is neoplasm.